NCT05543837View on ClinicalTrials.gov

Capsaicin for Cerebral Perfusion Augmentation

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 20, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

February 28, 2023

Conditions
Cerebral Circulatory Disorder
Interventions
DRUG

Capsaicin

Patients will receive a fixed dose of capsaicin

Trial Locations (1)

20259

Centenario Hospital Miguel Hidalgo, Aguascalientes

All Listed Sponsors
collaborator

Centenario Hospital Miguel Hidalgo

OTHER

lead

Instituto Mexicano del Seguro Social

OTHER_GOV